抗真菌藥物的全球市場，規模，佔有率，趨勢，產業分析報告:各類藥物，各適應症，各劑型，各流通管道，各地區 - 市場預測，2025年～2034年

根據 Polaris Market Research 的最新研究，預計到 2034 年，抗真菌藥物市場規模將達到 232.2 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

抗真菌藥物市場專注於開發、生產和分銷用於治療各種真菌感染的藥物，這些感染會影響皮膚、指甲、黏膜和內臟器官。真菌疾病的發生率不斷上升，尤其是在接受癌症治療、器官移植和患有慢性疾病的免疫功能低下患者中，這推動了對有效抗真菌療法的穩定需求。

醫院內獲得性真菌感染的增加迫使醫療保健提供者將抗真菌藥物納入其預防和治療方案中。行業趨勢表明，標靶治療、改進的藥物傳輸系統以及使用新型製劑來克服抗藥性和毒性問題正逐漸成為主流。包括外用、口服和靜脈注射的給藥平台的持續創新，正在提高患者的依從性和治療效果。製藥公司也正在投資新一代抗真菌藥物，以對抗抗藥性菌株和侵襲性感染。

不斷擴展的診斷能力使早期發現成為可能，有助於改善治療效果並增加處方量。此外，在目前尚無最佳治療方法的特定適應症中開發抗真菌藥物，以及在服務不足的新興市場中擴大藥物可及性，也存在著發展機會。各公司越來越注重現有藥物的生命週期管理，包括藥物配方的改良和複方製劑的研發。此外，旨在應對抗菌素抗藥性的全球衛生倡議為資金和合作創造了機會，使抗真菌領域成為臨床研究的活躍領域。技術和治療方法的進步，加上對病人安全的日益重視，推動了抗真菌藥物市場透過競爭和創新不斷發展。

抗黴菌藥物市場報告重點

依藥物類別劃分，唑類藥物憑藉其廣譜活性和在治療表淺和全身性真菌感染方面已證實的臨床療效，在2024年佔總銷售額的48%。

按適應症劃分，念珠菌症在2024年佔最大的銷售額佔有率，因為其在免疫功能低下和住院患者中患病率很高。

預計到2024年，北美將佔全球抗真菌藥物市場收入的約41%，這得益於其先進的醫療基礎設施、免疫抑制療法的頻繁使用以及老齡人口的增長。

預計亞太地區將在預測期內實現最高的複合年增長率，因為該地區醫療保健的可及性迅速改善以及人們對真菌感染的認識不斷提高。

主要的全球公司包括雅培、安斯泰來製藥、拜耳、Enzon Pharmaceuticals、Glenmark、葛蘭素史克、默克、諾華、輝瑞和賽諾菲。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 抗真菌藥物市場洞察

• 市場概述
• 抗真菌藥物市場動態
  • 促進因素和機會
    • 老年人口成長
    • 真菌感染的盛行率
  • 限制與課題
    • 產品成本高
• PESTEL分析
• 抗真菌藥物市場力量的評估趨勢
• 價值鏈分析

第5章 抗真菌藥物市場:各類藥物

• 主要調查結果
• 簡介
• Azole
• Echinocandins
• Polyenes
• 丙烯基胺
• 其他

第6章 抗真菌藥物市場:各適應症

• 主要調查結果
• 簡介
• 皮膚絲狀菌症
• 麴菌症
• 念珠菌症
• 其他

第7章 抗真菌藥物市場:各劑型

• 主要調查結果
• 簡介
• 口服藥
• 軟膏
• 粉末
• 其他

第8章 抗真菌藥物市場:各流通管道

• 主要調查結果
• 簡介
• 醫院藥局
• 零售藥局
• 其他

第9章 抗真菌藥物市場:各地區

• 主要調查結果
• 簡介
  • 抗真菌藥物市場分析:各地區，2020～2034年
• 北美
  • 北美:各類藥物，2020-2034年
  • 北美:各適應症，2020～2034年
  • 北美:各流通管道，2020～2034年
  • 北美:各劑型，2020～2034年
  • 美國
  • 加拿大
• 歐洲
  • 歐洲:各類藥物，2020-2034年
  • 歐洲:各適應症，2020～2034年
  • 歐洲:各流通管道，2020～2034年
  • 歐洲:各劑型，2020～2034年
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 荷蘭
  • 俄羅斯
  • 其他歐洲
• 亞太地區
  • 亞太地區:各類藥物，2020年～2034年
  • 亞太地區:各適應症，2020～2034年
  • 亞太地區:各流通管道，2020～2034年
  • 亞太地區:各劑型，2020～2034年
  • 中國
  • 印度
  • 馬來西亞
  • 日本
  • 印尼
  • 韓國
  • 澳洲
  • 其他亞太地區
• 中東·非洲
  • 中東·非洲:各類藥物，2020～2034年
  • 中東·非洲:不同症狀，2020～2034年
  • 中東·非洲:各流通管道，2020～2034年
  • 中東·非洲:各劑型，2020～2034年
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 其他中東·非洲
• 南美
  • 南美:各類藥物，2020-2034年
  • 南美:各徵兆，2020-2034年
  • 南美:各流通管道，2020～2034年
  • 南美:各劑型，2020～2034年
  • 墨西哥
  • 巴西
  • 阿根廷
  • 其他南美國家

第10章 競爭情形

• 擴大和收購的分析
  • 擴大
  • 收購
• 聯盟/合作/協定/公開

第11章 企業簡介

• Abbott
• Astellas Pharma, Inc.
• Bayer AG
• Enzon Pharmaceuticals, Inc.
• Glenmark
• GSK plc
• Merck & Co., Inc.
• Novartis AG
• Pfizer, Inc
• Sanofi

The antifungal drugs market size is expected to reach USD 23.22 billion by 2034, according to a new study by Polaris Market Research. The report "Antifungal Drugs Market Size, Share, Trend, Industry Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication, By Dosage Form, By Distribution Channel, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The antifungal drugs market focuses on the development, production, and distribution of medications used to treat a wide range of fungal infections affecting the skin, nails, mucous membranes, and internal organs. Rising cases of fungal diseases, particularly among immunocompromised individuals undergoing cancer treatments, organ transplantation, or suffering from chronic illnesses, are driving steady demand for effective antifungal therapies.

The increasing incidence of hospital-acquired fungal infections is pushing healthcare providers to incorporate antifungal agents into preventive and treatment protocols. Industry trends indicate a shift toward the use of targeted therapies, improved drug delivery systems, and novel formulations designed to overcome resistance and toxicity issues. Continuous innovation in topical, oral, and intravenous delivery platforms is enhancing patient adherence and treatment efficacy. Pharmaceutical companies are also investing in new-generation antifungal agents that target resistant strains and invasive infections.

Expanding diagnostic capabilities are enabling early detection, which improves outcomes and fuels prescription volumes. Opportunities lie in developing antifungal solutions for specific indications that currently lack optimal treatments, as well as expanding access in underserved healthcare markets. Companies are increasingly focusing on the lifecycle management of established drugs, including reformulation and fixed-dose combinations. Additionally, global health initiatives aimed at tackling antimicrobial resistance are creating room for funding and partnerships, making the antifungal space an active area for clinical research. The growing emphasis on patient safety, combined with technological and therapeutic advancements, continues to shape a competitive and innovation-driven antifungal drug landscape.

Antifungal Drugs Market Report Highlights

By drug class, the azoles drug segment accounted for ~48% of the revenue share in 2024 due to their broad-spectrum activity and established clinical effectiveness in treating both superficial and systemic fungal infections.

Based on indication, the candidiasis segment held the largest revenue share in 2024 due to its high prevalence among immunocompromised and hospitalized patients.

In 2024, North America accounted for a ~41% share of the global antifungal drugs market revenue due to the strong presence of advanced healthcare infrastructure, frequent use of immunosuppressive therapies, and a growing elderly population.

The market in Asia Pacific is expected to register the highest CAGR during the forecast period due to rapid improvements in healthcare access and growing awareness of fungal infections.

A few global key players include Abbott; Astellas Pharma, Inc.; Bayer AG; Enzon Pharmaceuticals, Inc.; Glenmark; GSK plc; Merck & Co., Inc.; Novartis AG; Pfizer, Inc.; and Sanofi.

Polaris Market Research has segmented the antifungal drugs market report on the basis of drug class, indication, dosage form, distribution channel, and region:

By Drug Class Outlook (Revenue, USD Billion, 2020-2034)

Azoles

Echinocandins

Polyenes

Allylamines

Others

By Indication Outlook (Revenue, USD Billion, 2020-2034)

Dermatophytosis

Aspergillosis

Candidiasis

Others

By Dosage Form Outlook (Revenue, USD Billion, 2020-2034)

Oral Drugs

Ointments

Powders

Others

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospital Pharmacies

Retail Pharmacies

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Antifungal Drugs Market Insights

• 4.1. Antifungal Drugs Market - Market Snapshot
• 4.2. Antifungal Drugs Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Growing Geriatric Population
    • 4.2.1.2. Rising Prevalence of Fungal Infections
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High costs of the products
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Antifungal Drugs Market Power Rating Trends
• 4.6. Value Chain Analysis

5. Antifungal Drugs Market, by Drug Class

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Antifungal Drugs Market, by Drug Class, 2020-2034 (USD Billion)
• 5.3. Azoles
  • 5.3.1. Antifungal Drugs Market, by Azoles, by Region, 2020-2034 (USD Billion)
• 5.4. Echinocandins
  • 5.4.1. Antifungal Drugs Market, by Echinocandins, by Region, 2020-2034 (USD Billion)
• 5.5. Polyenes
  • 5.5.1. Antifungal Drugs Market, by Polyenes, by Region, 2020-2034 (USD Billion)
• 5.6. Allylamines
  • 5.6.1. Antifungal Drugs Market, by Allylamines, by Region, 2020-2034 (USD Billion)
• 5.7. Others
  • 5.7.1. Antifungal Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

6. Antifungal Drugs Market, by Indication

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• 6.3. Dermatophytosis
  • 6.3.1. Antifungal Drugs Market, by Dermatophytosis, by Region, 2020-2034 (USD Billion)
• 6.4. Aspergillosis
  • 6.4.1. Antifungal Drugs Market, by Aspergillosis, by Region, 2020-2034 (USD Billion)
• 6.5. Candidiasis
  • 6.5.1. Antifungal Drugs Market, by Candidiasis, by Region, 2020-2034 (USD Billion)
• 6.6. Others
  • 6.6.1. Antifungal Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

7. Antifungal Drugs Market, by Dosage Form

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• 7.3. Oral Drugs
  • 7.3.1. Antifungal Drugs Market, by Oral Drugs, by Region, 2020-2034 (USD Billion)
• 7.4. Ointments
  • 7.4.1. Antifungal Drugs Market, by Ointments, by Region, 2020-2034 (USD Billion)
• 7.5. Powders
  • 7.5.1. Antifungal Drugs Market, by Powders, by Region, 2020-2034 (USD Billion)
• 7.6. Others
  • 7.6.1. Antifungal Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

8. Antifungal Drugs Market, by Distribution Channel

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• 8.3. Hospital Pharmacies
  • 8.3.1. Antifungal Drugs Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
• 8.4. Retail Pharmacies
  • 8.4.1. Antifungal Drugs Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
• 8.5. Others
  • 8.5.1. Antifungal Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

9. Antifungal Drugs Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Antifungal Drugs Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Antifungal Drugs Market - North America
  • 9.3.1. North America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
  • 9.3.2. North America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
  • 9.3.3. North America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.3.4. North America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.3.5. Antifungal Drugs Market - US
    • 9.3.5.1. US: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.3.5.2. US: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.3.5.3. US: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.3.5.4. US: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.3.6. Antifungal Drugs Market - Canada
    • 9.3.6.1. Canada: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• 9.4. Antifungal Drugs Market - Europe
  • 9.4.1. Europe: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.5. Antifungal Drugs Market - UK
    • 9.4.5.1. UK: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.6. Antifungal Drugs Market - France
    • 9.4.6.1. France: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.7. Antifungal Drugs Market - Germany
    • 9.4.7.1. Germany: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.8. Antifungal Drugs Market - Italy
    • 9.4.8.1. Italy: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.9. Antifungal Drugs Market - Spain
    • 9.4.9.1. Spain: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.10. Antifungal Drugs Market - Netherlands
    • 9.4.10.1. Netherlands: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.11. Antifungal Drugs Market - Russia
    • 9.4.11.1. Russia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.12. Antifungal Drugs Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• 9.5. Antifungal Drugs Market - Asia Pacific
  • 9.5.1. Asia Pacific: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.5. Antifungal Drugs Market - China
    • 9.5.5.1. China: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.6. Antifungal Drugs Market - India
    • 9.5.6.1. India: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.7. Antifungal Drugs Market - Malaysia
    • 9.5.7.1. Malaysia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.8. Antifungal Drugs Market - Japan
    • 9.5.8.1. Japan: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.9. Antifungal Drugs Market - Indonesia
    • 9.5.9.1. Indonesia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.10. Antifungal Drugs Market - South Korea
    • 9.5.10.1. South Korea: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.11. Antifungal Drugs Market - Australia
    • 9.5.11.1. Australia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.12. Antifungal Drugs Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• 9.6. Antifungal Drugs Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.6.5. Antifungal Drugs Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.6.6. Antifungal Drugs Market - UAE
    • 9.6.6.1. UAE: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.6.7. Antifungal Drugs Market - Israel
    • 9.6.7.1. Israel: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.6.8. Antifungal Drugs Market - South Africa
    • 9.6.8.1. South Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.6.9. Antifungal Drugs Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• 9.7. Antifungal Drugs Market - Latin America
  • 9.7.1. Latin America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.7.5. Antifungal Drugs Market - Mexico
    • 9.7.5.1. Mexico: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.7.6. Antifungal Drugs Market - Brazil
    • 9.7.6.1. Brazil: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.7.7. Antifungal Drugs Market - Argentina
    • 9.7.7.1. Argentina: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.7.8. Antifungal Drugs Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbott
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Astellas Pharma, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Bayer AG
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Enzon Pharmaceuticals, Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Glenmark
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. GSK plc
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Merck & Co., Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Novartis AG
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Pfizer, Inc
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Sanofi
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development

List of Tables:

• Table 1 Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 2 Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 3 Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 4 Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 5 North America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 6 North America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 7 North America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 8 North America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 9 US: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 10 US: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 11 US: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 12 US: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 13 Canada: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 14 Canada: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 15 Canada: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 16 Canada: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 17 Europe: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 18 Europe: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 19 Europe: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 20 Europe: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 21 UK: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 22 UK: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 23 UK: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 24 UK: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 25 France: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 26 France: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 27 France: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 28 France: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 29 Germany: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 30 Germany: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 31 Germany: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 32 Germany: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 33 Italy: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 34 Italy: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 35 Italy: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 36 Italy: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 37 Spain: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 38 Spain: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 39 Spain: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 40 Spain: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 41 Netherlands: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 42 Netherlands: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 43 Netherlands: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 44 Netherlands: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 45 Russia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 46 Russia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 47 Russia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 48 Russia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 57 China: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 58 China: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 59 China: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 60 China: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 61 India: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 62 India: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 63 India: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 64 India: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 65 Malaysia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 66 Malaysia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 67 Malaysia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 68 Malaysia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 69 Japan: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 70 Japan: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 71 Japan: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 72 Japan: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 73 Indonesia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 74 Indonesia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 75 Indonesia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 76 Indonesia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 77 South Korea: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 78 South Korea: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 79 South Korea: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 80 South Korea: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 81 Australia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 82 Australia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 83 Australia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 84 Australia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 97 UAE: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 98 UAE: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 99 UAE: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 100 UAE: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 101 Israel: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 102 Israel: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 103 Israel: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 104 Israel: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 105 South Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 106 South Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 107 South Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 108 South Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 113 Latin America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 114 Latin America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 115 Latin America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 116 Latin America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 117 Mexico: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 118 Mexico: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 119 Mexico: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 120 Mexico: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 121 Brazil: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 122 Brazil: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 123 Brazil: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 124 Brazil: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 125 Argentina: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 126 Argentina: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 127 Argentina: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 128 Argentina: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Antifungal Drugs Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Drug Class
• Figure 7. Antifungal Drugs Market, By Drug Class, 2024 & 2034 (USD Billion)
• Figure 8. Market by Indication
• Figure 9. Antifungal Drugs Market, By Indication, 2024 & 2034 (USD Billion)
• Figure 10. Market by Distribution Channel
• Figure 11. Antifungal Drugs Market, by Distribution Channel, 2024 & 2034 (USD Billion)
• Figure 12. Market by Dosage Form
• Figure 13. Antifungal Drugs Market, by Dosage Form, 2024 & 2034 (USD Billion)